Stocks · News reference
Bridge Neurotech ("Bridge"), which emerged from stealth today with the goal of building a completely non-invasive brain-computer interface (BCI), and Butterfly Network, Inc. ("Butterfly") (NYSE:BFLY), a
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Canaccord Genuity analyst William Plovanic initiates coverage on Butterfly Network (NYSE:BFLY) with a Buy rating and announces Price Target of $10.
Butterfly Network and Bridge Neurotech partner to build a non-invasive, ultrasound-based brain-computer interface (BCI) using AI decoding.
Filed: 2026-10-05 AccNo: 0001804176-26-000033 Size: 187 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits